Developing a vaccine to treat triple negative breast cancer
Dr Lee-Hwa Tai is developing a personalized immunotherapy vaccine to treat one of the most difficult-to-treat types of breast cancer.
Charity Partner
Research Institute
Researcher
Dr Lee-Hwa Tai
2nd
Breast cancer is the second leading cause of cancer death in Canadian women, with an estimated 5,500 deaths in 2021.
With enough community interest, this project will go live for funding. Join the list of future supporters today.
$544,900
Funding goal when this project goes live for fundraising.
Project Summary
Dr Lee-Hwa Tai is developing an immunotherapy vaccine to treat triple negative breast cancer, one of the most difficult to treat types of breast cancer.
Dr Tai’s team has already discovered that combining a person’s own tumour cells with a cancer-killing virus to create a vaccine leads to a strong anti-tumour immune response. Now, Dr. Tai is studying the different parts of the immune response to identify and test factors that can boost this strategy’s effectiveness.
If successful, this personalized strategy would provide a much-needed treatment option for people with triple negative breast cancer, helping them live longer, fuller lives.
| Research Team |